{"transactions":[{"id":4637931,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":48950,"kind":"person","name":"Douglass Brian Robb","position":1,"cik":"0002104618","reported_name":"Douglass Brian Robb","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PRODUCT OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-08T20:40:07.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"225 shares will vest on each of October 6, 2027, October 6, 2028, and October 6, 2029."}],"balance_after":675,"derivative":{"exercise_price":174.86,"expiration_date":"2036-10-06","underlying":"Common Stock","underlying_shares":675},"source":{"system":"sec-edgar","filing":"0001628280-26-065462","document":"wk-form4_1791492005.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2104618/000162828026065462/wk-form4_1791492005.xml","form_type":"4"}},{"id":4637930,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":48950,"kind":"person","name":"Douglass Brian Robb","position":1,"cik":"0002104618","reported_name":"Douglass Brian Robb","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PRODUCT OFFICER"}}],"security":"Common Stock","published_at":"2026-10-08T20:40:07.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Douglass was awarded 700 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":8685,"source":{"system":"sec-edgar","filing":"0001628280-26-065462","document":"wk-form4_1791492005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2104618/000162828026065462/wk-form4_1791492005.xml","form_type":"4"}},{"id":4636091,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-06T20:18:26.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":false,"shares":4202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"4,202 shares will vest on October 2, 2027. 4,203 shares will vest on October 2, 2028."}],"balance_after":8405,"derivative":{"exercise_price":154.96,"expiration_date":"2033-10-02","underlying":"Common Stock","underlying_shares":4202},"source":{"system":"sec-edgar","filing":"0001628280-26-065238","document":"wk-form4_1791317904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026065238/wk-form4_1791317904.xml","form_type":"4"}},{"id":4636090,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-06T20:18:26.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":4202,"price":190,"value":798380.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":45788,"source":{"system":"sec-edgar","filing":"0001628280-26-065238","document":"wk-form4_1791317904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026065238/wk-form4_1791317904.xml","form_type":"4"}},{"id":4636089,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-06T20:18:26.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":true,"shares":4202,"price":154.96,"value":651141.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":49990,"source":{"system":"sec-edgar","filing":"0001628280-26-065238","document":"wk-form4_1791317904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026065238/wk-form4_1791317904.xml","form_type":"4"}},{"id":4636088,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-06T20:18:26.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":1333,"price":178.75,"value":238273.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":45788,"source":{"system":"sec-edgar","filing":"0001628280-26-065238","document":"wk-form4_1791317904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026065238/wk-form4_1791317904.xml","form_type":"4"}},{"id":4629612,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-05T20:01:21.000Z","date":"2026-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1248,"price":181.7,"value":226761.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":47121,"source":{"system":"sec-edgar","filing":"0001628280-26-064889","document":"wk-form4_1791230479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026064889/wk-form4_1791230479.xml","form_type":"4"}},{"id":4627491,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":29970,"kind":"person","name":"Garland Jason K","position":1,"cik":"0001754555","reported_name":"Garland Jason K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-09-28T20:05:54.000Z","date":"2026-09-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":421,"price":189.68,"value":79855.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":18408,"source":{"system":"sec-edgar","filing":"0001628280-26-063714","document":"wk-form4_1790625949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754555/000162828026063714/wk-form4_1790625949.xml","form_type":"4"}},{"id":4626922,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-25T20:09:43.000Z","date":"2026-09-24","kind":"exercise","planned":true,"acquired":false,"shares":4542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"4,542 shares will vest on March 1, 2027, and 4,543 shares will vest on March 1, 2028."}],"balance_after":9085,"derivative":{"exercise_price":155.38,"expiration_date":"2035-03-01","underlying":"Common Stock","underlying_shares":4542},"source":{"system":"sec-edgar","filing":"0001628280-26-063572","document":"wk-form4_1790366980.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063572/wk-form4_1790366980.xml","form_type":"4"}},{"id":4626921,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-25T20:09:43.000Z","date":"2026-09-24","kind":"exercise","planned":true,"acquired":false,"shares":8404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"4,202 shares will vest on each of October 2, 2026, and October 2, 2027. 4,203 shares will vest on October 2, 2028."}],"balance_after":12607,"derivative":{"exercise_price":154.96,"expiration_date":"2033-10-02","underlying":"Common Stock","underlying_shares":8404},"source":{"system":"sec-edgar","filing":"0001628280-26-063572","document":"wk-form4_1790366980.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063572/wk-form4_1790366980.xml","form_type":"4"}},{"id":4626920,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-25T20:09:43.000Z","date":"2026-09-24","kind":"sale","planned":true,"acquired":false,"shares":4542,"price":190,"value":862980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":48369,"source":{"system":"sec-edgar","filing":"0001628280-26-063572","document":"wk-form4_1790366980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063572/wk-form4_1790366980.xml","form_type":"4"}},{"id":4626919,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-25T20:09:43.000Z","date":"2026-09-24","kind":"exercise","planned":true,"acquired":true,"shares":4542,"price":155.38,"value":705735.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":52911,"source":{"system":"sec-edgar","filing":"0001628280-26-063572","document":"wk-form4_1790366980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063572/wk-form4_1790366980.xml","form_type":"4"}},{"id":4626918,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-25T20:09:43.000Z","date":"2026-09-24","kind":"sale","planned":true,"acquired":false,"shares":8404,"price":190,"value":1596760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":48369,"source":{"system":"sec-edgar","filing":"0001628280-26-063572","document":"wk-form4_1790366980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063572/wk-form4_1790366980.xml","form_type":"4"}},{"id":4626917,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-25T20:09:43.000Z","date":"2026-09-24","kind":"exercise","planned":true,"acquired":true,"shares":8404,"price":154.96,"value":1302283.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":56773,"source":{"system":"sec-edgar","filing":"0001628280-26-063572","document":"wk-form4_1790366980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063572/wk-form4_1790366980.xml","form_type":"4"}},{"id":4624549,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-22T20:07:23.000Z","date":"2026-09-21","kind":"exercise","planned":true,"acquired":false,"shares":5426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":5426,"derivative":{"exercise_price":141.79,"exercise_date":"2027-09-03","expiration_date":"2034-09-03","underlying":"Common Stock","underlying_shares":5426},"source":{"system":"sec-edgar","filing":"0001628280-26-063026","document":"wk-form4_1790107640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063026/wk-form4_1790107640.xml","form_type":"4"}},{"id":4624548,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-22T20:07:23.000Z","date":"2026-09-21","kind":"sale","planned":true,"acquired":false,"shares":5426,"price":180,"value":976680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":48369,"source":{"system":"sec-edgar","filing":"0001628280-26-063026","document":"wk-form4_1790107640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063026/wk-form4_1790107640.xml","form_type":"4"}},{"id":4624547,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-22T20:07:23.000Z","date":"2026-09-21","kind":"exercise","planned":true,"acquired":true,"shares":5426,"price":141.79,"value":769352.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":53795,"source":{"system":"sec-edgar","filing":"0001628280-26-063026","document":"wk-form4_1790107640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063026/wk-form4_1790107640.xml","form_type":"4"}},{"id":3517271,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-08T20:13:40.000Z","date":"2026-09-04","kind":"sale","planned":true,"acquired":false,"shares":3035,"price":165.9,"value":503506.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":48369,"source":{"system":"sec-edgar","filing":"0001628280-26-060911","document":"wk-form4_1788898417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026060911/wk-form4_1788898417.xml","form_type":"4"}},{"id":3517270,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-08T20:13:40.000Z","date":"2026-09-03","kind":"tax_withholding","planned":true,"acquired":false,"shares":2842,"price":169.61,"value":482031.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":51404,"source":{"system":"sec-edgar","filing":"0001628280-26-060911","document":"wk-form4_1788898417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026060911/wk-form4_1788898417.xml","form_type":"4"}},{"id":518,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":487,"kind":"person","name":"Hughes Violetta","position":1,"cik":"0001991429","reported_name":"Hughes Violetta","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T20:18:30.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":277,"price":170.02,"value":47095.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":6331,"source":{"system":"sec-edgar","filing":"0001628280-26-060105","document":"wk-form4_1788380307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991429/000162828026060105/wk-form4_1788380307.xml","form_type":"4"}},{"id":517,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":487,"kind":"person","name":"Hughes Violetta","position":1,"cik":"0001991429","reported_name":"Hughes Violetta","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T20:18:30.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":2466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Ms. Hughes was awarded 2,466 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":6608,"source":{"system":"sec-edgar","filing":"0001628280-26-060105","document":"wk-form4_1788380307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991429/000162828026060105/wk-form4_1788380307.xml","form_type":"4"}},{"id":679438,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-21T20:06:30.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":false,"shares":5426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"5,426 shares will vest on each of September 3, 2026, and September 3, 2027."}],"balance_after":10852,"derivative":{"exercise_price":141.79,"expiration_date":"2034-09-03","underlying":"Common Stock","underlying_shares":5426},"source":{"system":"sec-edgar","filing":"0001628280-26-058417","document":"wk-form4_1787342788.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/730272/000162828026058417/wk-form4_1787342788.xml","form_type":"4"}},{"id":679437,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-21T20:06:30.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":5426,"price":180,"value":976680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":54246,"source":{"system":"sec-edgar","filing":"0001628280-26-058417","document":"wk-form4_1787342788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000162828026058417/wk-form4_1787342788.xml","form_type":"4"}},{"id":679436,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-21T20:06:30.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":true,"shares":5426,"price":141.79,"value":769352.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":59672,"source":{"system":"sec-edgar","filing":"0001628280-26-058417","document":"wk-form4_1787342788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000162828026058417/wk-form4_1787342788.xml","form_type":"4"}},{"id":707710,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":29970,"kind":"person","name":"Garland Jason K","position":1,"cik":"0001754555","reported_name":"Garland Jason K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-07-17T20:40:41.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":530,"price":150,"value":79500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025."}],"balance_after":18829,"source":{"system":"sec-edgar","filing":"0001193125-26-307925","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526307925/ownership.xml","form_type":"4"}},{"id":726045,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":29970,"kind":"person","name":"Garland Jason K","position":1,"cik":"0001754555","reported_name":"Garland Jason K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-06-26T20:05:11.000Z","date":"2026-06-25","kind":"sale","planned":true,"acquired":false,"shares":733,"price":145,"value":106285.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on  December 8, 2025."}],"balance_after":19359,"source":{"system":"sec-edgar","filing":"0001193125-26-285449","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526285449/ownership.xml","form_type":"4"}},{"id":776228,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":28423,"kind":"person","name":"Madaus Martin D","position":1,"cik":"0001310268","reported_name":"Madaus Martin D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:05:09.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":2239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":2239,"derivative":{"exercise_price":103.38,"exercise_date":"2027-05-14","expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":2239},"source":{"system":"sec-edgar","filing":"0001193125-26-228896","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228896/ownership.xml","form_type":"4"}},{"id":776227,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":28423,"kind":"person","name":"Madaus Martin D","position":1,"cik":"0001310268","reported_name":"Madaus Martin D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:05:09.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Madaus was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The Reporting Person has elected to defer settlement of these restricted stock units pursuant to the Repligen Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the separation of the Reporting Person's service as a Director. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":6581,"source":{"system":"sec-edgar","filing":"0001193125-26-228896","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228896/ownership.xml","form_type":"4"}},{"id":776226,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:05:08.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":2239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":2239,"derivative":{"exercise_price":103.38,"exercise_date":"2027-05-14","expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":2239},"source":{"system":"sec-edgar","filing":"0001193125-26-228897","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228897/ownership.xml","form_type":"4"}},{"id":776225,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46697,"kind":"person","name":"Konstantinov Konstantin","position":1,"cik":"0001774649","reported_name":"Konstantinov Konstantin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:05:08.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Konstantinov was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":3889,"source":{"system":"sec-edgar","filing":"0001193125-26-228897","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228897/ownership.xml","form_type":"4"}},{"id":776224,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46696,"kind":"person","name":"EGLINTON MANNER CARRIE","position":1,"cik":"0001696776","reported_name":"EGLINTON MANNER CARRIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:05:07.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":2239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":2239,"derivative":{"exercise_price":103.38,"exercise_date":"2027-05-14","expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":2239},"source":{"system":"sec-edgar","filing":"0001193125-26-228893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228893/ownership.xml","form_type":"4"}},{"id":776223,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46696,"kind":"person","name":"EGLINTON MANNER CARRIE","position":1,"cik":"0001696776","reported_name":"EGLINTON MANNER CARRIE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:05:07.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Ms. Manner was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":5461,"source":{"system":"sec-edgar","filing":"0001193125-26-228893","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228893/ownership.xml","form_type":"4"}},{"id":776222,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":40052,"kind":"person","name":"Mhatre Rohin","position":1,"cik":"0001798735","reported_name":"Mhatre Rohin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:05:07.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":2239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":2239,"derivative":{"exercise_price":103.38,"exercise_date":"2027-05-14","expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":2239},"source":{"system":"sec-edgar","filing":"0001193125-26-228888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228888/ownership.xml","form_type":"4"}},{"id":776221,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":40052,"kind":"person","name":"Mhatre Rohin","position":1,"cik":"0001798735","reported_name":"Mhatre Rohin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:05:07.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Mhatre was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":5014,"source":{"system":"sec-edgar","filing":"0001193125-26-228888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228888/ownership.xml","form_type":"4"}},{"id":776220,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46695,"kind":"person","name":"Pax Margaret","position":1,"cik":"0001999772","reported_name":"Pax Margaret","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:05:06.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":2239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":2239,"derivative":{"exercise_price":103.38,"exercise_date":"2027-05-14","expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":2239},"source":{"system":"sec-edgar","filing":"0001193125-26-228886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228886/ownership.xml","form_type":"4"}},{"id":776219,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46695,"kind":"person","name":"Pax Margaret","position":1,"cik":"0001999772","reported_name":"Pax Margaret","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:05:06.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Ms. Pax was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":3011,"source":{"system":"sec-edgar","filing":"0001193125-26-228886","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228886/ownership.xml","form_type":"4"}},{"id":776218,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:05:04.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":2239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":2239,"derivative":{"exercise_price":103.38,"exercise_date":"2027-05-14","expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":2239},"source":{"system":"sec-edgar","filing":"0001193125-26-228891","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228891/ownership.xml","form_type":"4"}},{"id":776217,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:05:04.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Muir was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The Reporting Person has elected to defer settlement of these restricted stock units pursuant to the Repligen Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the separation of the Reporting Person's service as a Director. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":40051,"source":{"system":"sec-edgar","filing":"0001193125-26-228891","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228891/ownership.xml","form_type":"4"}},{"id":776216,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46694,"kind":"person","name":"DAWES KAREN A","position":1,"cik":"0001261506","reported_name":"DAWES KAREN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:05:04.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":2239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":2239,"derivative":{"exercise_price":103.38,"exercise_date":"2027-05-14","expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":2239},"source":{"system":"sec-edgar","filing":"0001193125-26-228884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228884/ownership.xml","form_type":"4"}},{"id":776215,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46694,"kind":"person","name":"DAWES KAREN A","position":1,"cik":"0001261506","reported_name":"DAWES KAREN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:05:04.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Ms. Dawes was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":92816,"source":{"system":"sec-edgar","filing":"0001193125-26-228884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228884/ownership.xml","form_type":"4"}},{"id":776213,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46693,"kind":"person","name":"BARTHELEMY NICOLAS","position":1,"cik":"0001283576","reported_name":"BARTHELEMY NICOLAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:05:02.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":2239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":2239,"derivative":{"exercise_price":103.38,"exercise_date":"2027-05-14","expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":2239},"source":{"system":"sec-edgar","filing":"0001193125-26-228883","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228883/ownership.xml","form_type":"4"}},{"id":776212,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46693,"kind":"person","name":"BARTHELEMY NICOLAS","position":1,"cik":"0001283576","reported_name":"BARTHELEMY NICOLAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:05:02.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Barthelemy was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The Reporting Person has elected to defer settlement of these restricted stock units pursuant to the Repligen Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the separation of the Reporting Person's service as a Director. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":5436,"source":{"system":"sec-edgar","filing":"0001193125-26-228883","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228883/ownership.xml","form_type":"4"}},{"id":787891,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T18:48:02.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":2434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested and exercisable."}],"balance_after":2434,"derivative":{"exercise_price":38.76,"expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":2434},"source":{"system":"sec-edgar","filing":"0001193125-26-214293","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526214293/ownership.xml","form_type":"4"}},{"id":787890,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-08T18:48:02.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":2434,"price":38.76,"value":94341.84,"ownership":{"direct":true},"balance_after":39056,"source":{"system":"sec-edgar","filing":"0001193125-26-214293","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526214293/ownership.xml","form_type":"4"}},{"id":787889,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":48950,"kind":"person","name":"Douglass Brian Robb","position":1,"cik":"0002104618","reported_name":"Douglass Brian Robb","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PRODUCT OFFICER"}}],"security":"Common Stock","published_at":"2026-05-08T18:39:43.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":334,"price":126.43,"value":42227.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":7985,"source":{"system":"sec-edgar","filing":"0001193125-26-214265","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526214265/ownership.xml","form_type":"4"}},{"id":803401,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-22T17:26:04.000Z","date":"2026-04-21","kind":"sale","planned":true,"acquired":false,"shares":3832,"price":140,"value":536480.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on August 19th, 2025."}],"balance_after":54246,"source":{"system":"sec-edgar","filing":"0001193125-26-169682","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526169682/ownership.xml","form_type":"4"}},{"id":831658,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":56715,"kind":"person","name":"KURIYEL RALF","position":1,"cik":"0001733143","reported_name":"KURIYEL RALF","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-23T16:00:33.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":5669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029."}],"balance_after":5669,"derivative":{"exercise_price":141.91,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":5669},"source":{"system":"sec-edgar","filing":"0001193125-26-119047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526119047/ownership.xml","form_type":"4"}},{"id":831657,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":56715,"kind":"person","name":"KURIYEL RALF","position":1,"cik":"0001733143","reported_name":"KURIYEL RALF","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, R&D"}}],"security":"Common Stock","published_at":"2026-03-23T16:00:33.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":5284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Kuriyel was awarded 5,284 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":20062,"source":{"system":"sec-edgar","filing":"0001193125-26-119047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526119047/ownership.xml","form_type":"4"}},{"id":831656,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-23T15:53:49.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":25890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029."}],"balance_after":25890,"derivative":{"exercise_price":141.91,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":25890},"source":{"system":"sec-edgar","filing":"0001193125-26-119036","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526119036/ownership.xml","form_type":"4"}},{"id":831655,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-23T15:53:49.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":24134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Loeillot was awarded 24,134 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":58078,"source":{"system":"sec-edgar","filing":"0001193125-26-119036","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526119036/ownership.xml","form_type":"4"}},{"id":831654,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":56714,"kind":"person","name":"Bylund James","position":1,"cik":"0001849642","reported_name":"Bylund James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-23T15:53:02.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":8315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029."}],"balance_after":8315,"derivative":{"exercise_price":141.91,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":8315},"source":{"system":"sec-edgar","filing":"0001193125-26-119034","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526119034/ownership.xml","form_type":"4"}},{"id":831653,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":56714,"kind":"person","name":"Bylund James","position":1,"cik":"0001849642","reported_name":"Bylund James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-23T15:53:02.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":7751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Bylund was awarded 7,751 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":25423,"source":{"system":"sec-edgar","filing":"0001193125-26-119034","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526119034/ownership.xml","form_type":"4"}},{"id":831652,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":29970,"kind":"person","name":"Garland Jason K","position":1,"cik":"0001754555","reported_name":"Garland Jason K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-23T15:51:37.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":8315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029."}],"balance_after":8315,"derivative":{"exercise_price":141.91,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":8315},"source":{"system":"sec-edgar","filing":"0001193125-26-119031","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526119031/ownership.xml","form_type":"4"}},{"id":831651,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":29970,"kind":"person","name":"Garland Jason K","position":1,"cik":"0001754555","reported_name":"Garland Jason K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-03-23T15:51:37.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":7751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Garland was awarded 7,751 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":20092,"source":{"system":"sec-edgar","filing":"0001193125-26-119031","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526119031/ownership.xml","form_type":"4"}},{"id":860109,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":56714,"kind":"person","name":"Bylund James","position":1,"cik":"0001849642","reported_name":"Bylund James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-05T18:28:48.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":62,"price":125.84,"value":7802.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of the performance stock units."}],"balance_after":17672,"source":{"system":"sec-edgar","filing":"0001193125-26-093379","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526093379/ownership.xml","form_type":"4"}},{"id":860108,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":56714,"kind":"person","name":"Bylund James","position":1,"cik":"0001849642","reported_name":"Bylund James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-05T18:28:48.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 125 shares issued pursuant to a Performance Stock Unit (\"PSU\") award granted to the Issuer on January 1, 2025. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award."}],"balance_after":17734,"source":{"system":"sec-edgar","filing":"0001193125-26-093379","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526093379/ownership.xml","form_type":"4"}},{"id":860107,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":56715,"kind":"person","name":"KURIYEL RALF","position":1,"cik":"0001733143","reported_name":"KURIYEL RALF","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, R&D"}}],"security":"Common Stock","published_at":"2026-03-05T18:25:03.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":42,"price":125.84,"value":5285.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of the performance stock units."}],"balance_after":14778,"source":{"system":"sec-edgar","filing":"0001193125-26-093368","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526093368/ownership.xml","form_type":"4"}},{"id":860106,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":56715,"kind":"person","name":"KURIYEL RALF","position":1,"cik":"0001733143","reported_name":"KURIYEL RALF","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, R&D"}}],"security":"Common Stock","published_at":"2026-03-05T18:25:03.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 125 shares issued pursuant to a Performance Stock Unit (\"PSU\") award granted to the Issuer on January 1, 2025. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award."}],"balance_after":14820,"source":{"system":"sec-edgar","filing":"0001193125-26-093368","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526093368/ownership.xml","form_type":"4"}},{"id":872220,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":56714,"kind":"person","name":"Bylund James","position":1,"cik":"0001849642","reported_name":"Bylund James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-03T19:02:34.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2433,"price":124.97,"value":304052.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":17609,"source":{"system":"sec-edgar","filing":"0001193125-26-087669","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526087669/ownership.xml","form_type":"4"}},{"id":872219,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":56714,"kind":"person","name":"Bylund James","position":1,"cik":"0001849642","reported_name":"Bylund James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-03T19:02:34.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":1478,"price":128.73,"value":190262.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":20042,"source":{"system":"sec-edgar","filing":"0001193125-26-087669","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526087669/ownership.xml","form_type":"4"}},{"id":872218,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-03T18:39:26.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1610,"price":124.97,"value":201201.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":33944,"source":{"system":"sec-edgar","filing":"0001193125-26-087595","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526087595/ownership.xml","form_type":"4"}},{"id":872217,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-03T18:39:26.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":344,"price":128.73,"value":44283.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":35554,"source":{"system":"sec-edgar","filing":"0001193125-26-087595","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526087595/ownership.xml","form_type":"4"}},{"id":872216,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-03T18:38:29.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":9897,"price":124.97,"value":1236828.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":89062,"source":{"system":"sec-edgar","filing":"0001193125-26-087591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526087591/ownership.xml","form_type":"4"}},{"id":872215,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":29970,"kind":"person","name":"Garland Jason K","position":1,"cik":"0001754555","reported_name":"Garland Jason K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-03-03T18:33:27.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":715,"price":124.97,"value":89353.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":12341,"source":{"system":"sec-edgar","filing":"0001193125-26-087579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526087579/ownership.xml","form_type":"4"}},{"id":872214,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":29970,"kind":"person","name":"Garland Jason K","position":1,"cik":"0001754555","reported_name":"Garland Jason K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-03-03T18:33:27.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":327,"price":128.73,"value":42094.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":13056,"source":{"system":"sec-edgar","filing":"0001193125-26-087579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526087579/ownership.xml","form_type":"4"}},{"id":872213,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":56715,"kind":"person","name":"KURIYEL RALF","position":1,"cik":"0001733143","reported_name":"KURIYEL RALF","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, R&D"}}],"security":"Common Stock","published_at":"2026-03-03T18:30:52.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":923,"price":124.97,"value":115347.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":14695,"source":{"system":"sec-edgar","filing":"0001193125-26-087568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526087568/ownership.xml","form_type":"4"}},{"id":872212,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":56715,"kind":"person","name":"KURIYEL RALF","position":1,"cik":"0001733143","reported_name":"KURIYEL RALF","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, R&D"}}],"security":"Common Stock","published_at":"2026-03-03T18:30:52.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":444,"price":128.73,"value":57156.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":15618,"source":{"system":"sec-edgar","filing":"0001193125-26-087568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526087568/ownership.xml","form_type":"4"}},{"id":872211,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":48950,"kind":"person","name":"Douglass Brian Robb","position":1,"cik":"0002104618","reported_name":"Douglass Brian Robb","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PRODUCT OFFICER"}}],"security":"Common Stock","published_at":"2026-03-03T17:48:01.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":221,"price":124.97,"value":27618.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":8319,"source":{"system":"sec-edgar","filing":"0001193125-26-087447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526087447/ownership.xml","form_type":"4"}},{"id":941673,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":48950,"kind":"person","name":"Douglass Brian Robb","position":1,"cik":"0002104618","reported_name":"Douglass Brian Robb","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PRODUCT OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T21:32:03.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":2143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares will vest in substantially equal installments over a three-year period with each such vesting date occurring on the anniversary of the grant date."}],"balance_after":2143,"derivative":{"exercise_price":163.86,"expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":2143},"source":{"system":"sec-edgar","filing":"0001193125-26-010470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526010470/ownership.xml","form_type":"4"}},{"id":941672,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":48950,"kind":"person","name":"Douglass Brian Robb","position":1,"cik":"0002104618","reported_name":"Douglass Brian Robb","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PRODUCT OFFICER"}}],"security":"Common Stock","published_at":"2026-01-12T21:32:03.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":2288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Douglass was awarded 2,288 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in substantially equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock."}],"balance_after":8540,"source":{"system":"sec-edgar","filing":"0001193125-26-010470","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526010470/ownership.xml","form_type":"4"}},{"id":963890,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":46694,"kind":"person","name":"DAWES KAREN A","position":1,"cik":"0001261506","reported_name":"DAWES KAREN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-18T21:30:18.000Z","date":"2025-12-17","kind":"sale","planned":false,"acquired":false,"shares":275,"price":161,"value":44275.0,"ownership":{"direct":true},"balance_after":91821,"source":{"system":"sec-edgar","filing":"0001193125-25-324912","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525324912/ownership.xml","form_type":"4"}},{"id":966631,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-17T21:30:06.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":true,"shares":3366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested and exercisable."}],"balance_after":3366,"derivative":{"exercise_price":26.12,"expiration_date":"2026-05-11","underlying":"Common Stock","underlying_shares":3366},"source":{"system":"sec-edgar","filing":"0001193125-25-322821","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525322821/ownership.xml","form_type":"4"}},{"id":966630,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:30:06.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":true,"shares":3366,"price":26.12,"value":87919.92,"ownership":{"direct":true},"balance_after":36622,"source":{"system":"sec-edgar","filing":"0001193125-25-322821","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525322821/ownership.xml","form_type":"4"}},{"id":978434,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-08T21:30:03.000Z","date":"2025-12-04","kind":"other","planned":false,"acquired":false,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer of shares for which the Reporting Person is a joint tenant with right of survivorship."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a transfer of shares for which the Reporting Person is a joint tenant with right of survivorship."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents a transfer of shares for which the Reporting Person is a joint tenant with right of survivorship."}],"balance_after":98959,"source":{"system":"sec-edgar","filing":"0001193125-25-311290","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525311290/ownership.xml","form_type":"4"}},{"id":988078,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-26T21:30:04.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":7041,"price":170,"value":1196970.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 12, 2024."}],"balance_after":35898,"source":{"system":"sec-edgar","filing":"0001193125-25-300642","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525300642/ownership.xml","form_type":"4"}},{"id":994803,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":56714,"kind":"person","name":"Bylund James","position":1,"cik":"0001849642","reported_name":"Bylund James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-19T21:30:11.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":2191,"price":151.21,"value":331301.11,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"$151.21 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.21 to $151.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21520,"source":{"system":"sec-edgar","filing":"0001193125-25-288160","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525288160/ownership.xml","form_type":"4"}},{"id":999535,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-14T21:30:08.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"14,760 of the shares underlying this option have vested. The remaining shares vest as follows: 2,952 shares on March 1, 2026, and 2,952 shares on March 1, 2027."}],"balance_after":14760,"derivative":{"exercise_price":33.87,"expiration_date":"2028-02-29","underlying":"Common Stock","underlying_shares":2952},"source":{"system":"sec-edgar","filing":"0001193125-25-283092","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525283092/ownership.xml","form_type":"4"}},{"id":999534,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:30:08.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":true,"shares":2952,"price":33.87,"value":99984.24,"ownership":{"direct":true},"balance_after":83695,"source":{"system":"sec-edgar","filing":"0001193125-25-283092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525283092/ownership.xml","form_type":"4"}},{"id":999533,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:30:08.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":1956,"price":157.11,"value":307307.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"$157.11 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.90 to $157.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":80743,"source":{"system":"sec-edgar","filing":"0001193125-25-283092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525283092/ownership.xml","form_type":"4"}},{"id":999532,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:30:08.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":5737,"price":156.22,"value":896234.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"$156.22 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.79 to $156.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":82699,"source":{"system":"sec-edgar","filing":"0001193125-25-283092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525283092/ownership.xml","form_type":"4"}},{"id":999531,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:30:08.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":155.45,"value":466350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"$155.45 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.78 to $155.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":88436,"source":{"system":"sec-edgar","filing":"0001193125-25-283092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525283092/ownership.xml","form_type":"4"}},{"id":999530,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:30:08.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":154.32,"value":385800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"$154.32 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.66 to $154.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":91436,"source":{"system":"sec-edgar","filing":"0001193125-25-283092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525283092/ownership.xml","form_type":"4"}},{"id":999529,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:30:08.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":2923,"price":153.14,"value":447628.22,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"$153.14 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.64 to $153.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":93936,"source":{"system":"sec-edgar","filing":"0001193125-25-283092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525283092/ownership.xml","form_type":"4"}},{"id":999528,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:30:08.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":2100,"price":152.17,"value":319557.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"$152.17 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.57 to $152.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":96859,"source":{"system":"sec-edgar","filing":"0001193125-25-283092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525283092/ownership.xml","form_type":"4"}},{"id":999527,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:30:08.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":1784,"price":151.01,"value":269401.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"$151.01 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.53 to $151.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":98959,"source":{"system":"sec-edgar","filing":"0001193125-25-283092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525283092/ownership.xml","form_type":"4"}},{"id":1001118,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-13T21:30:08.000Z","date":"2025-11-12","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"207,344 of the shares underlying this option have vested. The remaining shares vest as follows: 28,777 shares on March 1, 2026, and 28,778 shares on March 1, 2027."}],"balance_after":157344,"derivative":{"exercise_price":33.87,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-25-280266","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525280266/ownership.xml","form_type":"4"}},{"id":1001117,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T21:30:08.000Z","date":"2025-11-12","kind":"sale","planned":true,"acquired":false,"shares":464,"price":158.51,"value":73548.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"$158.51 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.43 to $158.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":100743,"source":{"system":"sec-edgar","filing":"0001193125-25-280266","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525280266/ownership.xml","form_type":"4"}},{"id":1001116,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T21:30:08.000Z","date":"2025-11-12","kind":"sale","planned":true,"acquired":false,"shares":11096,"price":158.01,"value":1753278.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"$158.01 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.41 to $158.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":101207,"source":{"system":"sec-edgar","filing":"0001193125-25-280266","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525280266/ownership.xml","form_type":"4"}},{"id":1001115,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T21:30:08.000Z","date":"2025-11-12","kind":"sale","planned":true,"acquired":false,"shares":4959,"price":156.65,"value":776827.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"$156.65 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.31 to $157.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":112303,"source":{"system":"sec-edgar","filing":"0001193125-25-280266","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525280266/ownership.xml","form_type":"4"}},{"id":1001114,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T21:30:08.000Z","date":"2025-11-12","kind":"sale","planned":true,"acquired":false,"shares":4740,"price":155.85,"value":738729.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"$155.85 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.28 to $156.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":117262,"source":{"system":"sec-edgar","filing":"0001193125-25-280266","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525280266/ownership.xml","form_type":"4"}},{"id":1001113,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T21:30:08.000Z","date":"2025-11-12","kind":"sale","planned":true,"acquired":false,"shares":3741,"price":154.92,"value":579555.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"$154.92 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.26 to $155.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":122002,"source":{"system":"sec-edgar","filing":"0001193125-25-280266","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525280266/ownership.xml","form_type":"4"}},{"id":1001112,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-13T21:30:08.000Z","date":"2025-11-12","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":33.87,"value":846750.0,"ownership":{"direct":true},"balance_after":125743,"source":{"system":"sec-edgar","filing":"0001193125-25-280266","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525280266/ownership.xml","form_type":"4"}},{"id":1023791,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-06T14:59:45.000Z","date":"2025-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1248,"price":145.23,"value":181247.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":42939,"source":{"system":"sec-edgar","filing":"0001193125-25-231365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525231365/ownership.xml","form_type":"4"}},{"id":1032032,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":29970,"kind":"person","name":"Garland Jason K","position":1,"cik":"0001754555","reported_name":"Garland Jason K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-09-26T18:30:54.000Z","date":"2025-09-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":412,"price":121.68,"value":50132.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":13383,"source":{"system":"sec-edgar","filing":"0001193125-25-220202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525220202/ownership.xml","form_type":"4"}},{"id":1043515,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-11T18:55:01.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"207,344 of the shares underlying this option have vested. The remaining shares vest as follows: 28,777 shares on March 1, 2026, and 28,778 shares on March 1, 2027."}],"balance_after":182344,"derivative":{"exercise_price":33.87,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-25-201224","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525201224/ownership.xml","form_type":"4"}},{"id":1043514,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T18:55:01.000Z","date":"2025-09-10","kind":"sale","planned":false,"acquired":false,"shares":2179,"price":122.23,"value":266339.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"$122.23 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.92 to $122.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":100743,"source":{"system":"sec-edgar","filing":"0001193125-25-201224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525201224/ownership.xml","form_type":"4"}},{"id":1043513,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T18:55:01.000Z","date":"2025-09-10","kind":"sale","planned":false,"acquired":false,"shares":7584,"price":121.42,"value":920849.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"$121.42 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.86 to $121.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":102922,"source":{"system":"sec-edgar","filing":"0001193125-25-201224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525201224/ownership.xml","form_type":"4"}},{"id":1043512,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T18:55:01.000Z","date":"2025-09-10","kind":"sale","planned":false,"acquired":false,"shares":14882,"price":120.19,"value":1788667.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"$120.19 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.85 to $120.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":110506,"source":{"system":"sec-edgar","filing":"0001193125-25-201224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525201224/ownership.xml","form_type":"4"}},{"id":1043511,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T18:55:01.000Z","date":"2025-09-10","kind":"sale","planned":false,"acquired":false,"shares":3262,"price":119.64,"value":390265.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"$119.64 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.83 to $119.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":125388,"source":{"system":"sec-edgar","filing":"0001193125-25-201224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525201224/ownership.xml","form_type":"4"}},{"id":1043510,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":38580,"kind":"person","name":"Hunt Anthony","position":1,"cik":"0001606030","reported_name":"Hunt Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T18:55:01.000Z","date":"2025-09-10","kind":"sale","planned":false,"acquired":false,"shares":1108,"price":118.32,"value":131098.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"$118.32 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.80 to $118.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":128650,"source":{"system":"sec-edgar","filing":"0001193125-25-201224","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525201224/ownership.xml","form_type":"4"}}],"next_cursor":"2025-09-11T18:55:01.000000Z,1043510"}